There are 302 resources available
Q&A and discussion
Session: Not-for-profit IO research consortia: Ongoing research pipelines
Resources:
Webcast
Q&A and discussion
Session: Next generation cell therapies
Resources:
Webcast
172MO - Novel regulators of antigen presentation and therapeutic reactivation of MHC-I to overcome immune evasion in small cell lung cancer
Presenter: Triparna Sen
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
173MO - Immunological dynamics of HLA-II positive melanoma
Presenter: Mario Presti
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
3MO - LDH isoforms shape the immune microenvironment and impact treatment response and survival in metastatic melanoma
Presenter: Laura Soumoy
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
Invited Discussant 172MO, 173MO, and 3MO
Presenter: Aurélien Marabelle
Session: Mini Oral session 1
Resources:
Slides
Webcast
174MO - The A2AR antagonist inupadenant promotes humoral responses in patients
Presenter: Hussein Shehade
Session: Mini Oral session 1
Resources:
Abstract
4MO - Role of ctDNA tumor fraction to select immunotherapy based regimens in advanced non-small cell lung cancer
Presenter: Filippo Dall'Olio
Session: Mini Oral session 1
Resources:
Abstract
5MO - Novel radiologic phenotypes of chaotic tumor angiogenesis associated with poor ICI outcomes in NSCLC
Presenter: Vamsidhar Velcheti
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
6MO - Single-cell analysis of peripheral blood mononuclear cells reveals therapy outcomes are associated with pre-existing immunity in patients treated with oncolytic adenovirus armed with TNF_ and IL2
Presenter: Tatiana Kudling
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast